Blood protein map may reveal hidden clues in ovarian cancer treatment

NCT ID NCT07684846

Completed Knowledge-focused Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study looks at how proteins in the blood change in women with ovarian cancer as they go through standard treatment. Researchers collected blood samples before surgery, after surgery, and after chemotherapy to see if these protein shifts could give a fuller picture of how the body responds to treatment. The goal is to find new ways to monitor the disease beyond the usual blood tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to monitor ovarian cancer treatment response and detect recurrence earlier.
What could go wrong: This is a small observational study, not a treatment trial. The findings may not translate into clinical practice or benefit patients directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER OVARIAN CANCER RECURRENT

Contacts and locations

Show contact details

Locations

UMC Ljubljana

Ljubljana, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.